Inhaled corticosteroids in transient tachypnea of the newborn: A randomized, placebo-controlled study

Keyphrases

• Randomized Placebo-controlled Trial 100%
• Inhaled Corticosteroids 100%
• Transient Tachypnea 100%
• Gestational Age 50%
• Preterm Neonates 50%
• Clinical Score 50%
• Late Preterm Infant 50%
• Late Preterm 50%
• Placebo 25%
• Two-dose 25%
• Length of Stay 25%
• Vital Signs 25%
• Respiratory Rate 25%
• Intention-to-treat 25%
• Beneficial Effects 25%
• Clinical Course 25%
• Respiratory Support 25%
• Clinical Conditions 25%
• Respiratory Complications 25%
• Term Infants 25%
• Respiratory Distress 25%
• Inhalation 25%
• Antenatal Corticosteroids 25%
• Early Administration 25%
• Inhaled Steroids 25%
• Inhaled Budesonide 25%
• Ala Nasi 25%
• Respiratory Morbidity 25%
• Time to Full Feeds 25%
• Blood Gas 25%
• Grunt 25%
• Birth Characteristics 25%
• Score-based 25%
• Ventilation Support 25%

Medicine and Dentistry

• Placebo-Controlled Study 100%
• Transient Tachypnea of the Newborn 100%
• Placebo 50%
• Gestational Age 50%
• Intention-to-Treat Analysis 25%
• Childbirth 25%
• Vital Sign 25%
• Disease Course 25%
• Neonate 25%
• Breathing 25%
• Side Effect 25%
• Budesonide 25%
• Assisted Ventilation 25%
• Respiratory Distress 25%
• Ala of Nose 25%
• Blood Gas 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Placebo-Controlled Study 100%
• Transient Tachypnea of the Newborn 100%
• Placebo 50%
• Disease Course 25%
• Side Effect 25%
• Budesonide 25%
• Respiratory Distress 25%